1. Antiretroviral therapy-induced paradoxical worsening of previously healed Mycobacterium haemophilum cutaneous lesions in advanced HIV infection.
- Author
-
Eyer-Silva WA, Almeida MR, Martins CJ, Basílio-de-Oliveira RP, Araujo LF, Basílio-de-Oliveira CA, Azevedo MCVM, Pinto JFDC, Vasconcellos SEG, Rodrigues-Dos-Santos Í, MagdinierGomes H, and Suffys PN
- Subjects
- AIDS-Related Opportunistic Infections immunology, Adult, Anti-Retroviral Agents therapeutic use, CD4 Lymphocyte Count, Female, Humans, Immune Reconstitution Inflammatory Syndrome immunology, Immune Reconstitution Inflammatory Syndrome metabolism, Immunocompromised Host, Male, Mycobacterium Infections immunology, AIDS-Related Opportunistic Infections microbiology, Anti-Retroviral Agents adverse effects, Immune Reconstitution Inflammatory Syndrome microbiology, Mycobacterium Infections microbiology, Mycobacterium haemophilum isolation & purification
- Abstract
Mycobacterium haemophilum is a nontuberculous mycobacterium that causes localized or disseminated disease, mainly in immunocompromised hosts. We report the case of a 35-year-old HIV-infected woman who presented with several enlarging cutaneous lesions over the arms and legs. Histopathological examination revealed the diagnosis of a cutaneous mycobacterial disease. Mycobacterial analyses unveiled M. haemophilum infection. Six months after completion of a successful antimycobacterial treatment, she developed an immune reconstitution inflammatory syndrome (IRIS). This paradoxical relapse presented as tenderness, redness and swelling at the precise sites of the healed lesions and took place in the setting of significant recovery of the CD4 cell count (from 05 to 318 cells/mm 3 ). Microbiological analyses of these worsening lesions were negative, and they spontaneously remitted without the initiation of a novel antimycobacterial treatment cycle. M. haemophilum infection should always be considered as a cause of skin lesions in immunocompromised subjects. Physicians should be aware of the possibility of IRIS as a complication of successful antiretroviral therapy in HIV-infected patients with M. haemophilum infection.
- Published
- 2019
- Full Text
- View/download PDF